NTRA Nasdaq 2020 - 09 - 11

Natera, Inc.

NTRA | News S | $88.61 3.91% 3.8% 5

(0.0% 1d) (-3.0% 1m) (67.2% 1y) (0.0% 2d) (0.0% 3d) (-1.9% 7d) (-55.63% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 10,700,355,481
http://www.natera.com
Sec Filling | Patents | 1039 employees

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

genetic diagnostics

add to watch list Paper trade email alert is off

Press-releases

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| 3.9% | O: 1.38% H: 3.26% C: 2.49%
milestone

Liberty All-Star® Growth Fund, Inc. March 2024 Monthly Update
Published: 2024-04-12 (Crawled : 00:20) - prnewswire.com
AMZN S | $177.23 1.49% 2.0% 28M

Retail Trade

| Email alert Add to watchlist
CWST | $94.09 0.71% 0.75% 160K

Industrial Services

| Email alert Add to watchlist
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| Email alert Add to watchlist
PGNY | $33.06 1.1% 1.06% 0

Commercial Services

| Email alert Add to watchlist
SPSC | $168.64 1.9% 2.04% 220K

Technology Services

| Email alert Add to watchlist
TRNS | $111.35 3.06% 2.49% 33K

Electronic Technology

| Email alert Add to watchlist
VERX | News | $30.04 5.0% 4.73% 600K

Technology Services

| Email alert Add to watchlist
CR | $130.73 0.97% 8.82% 230K

Producer Manufacturing

| Email alert Add to watchlist
EME | $332.59 1.21% 0.21% 280K

Industrial Services

| Email alert Add to watchlist
SITE | $157.0 0.68% 0.0% 240K

Distribution Services

| Email alert Add to watchlist
star update liberty growth

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published: 2024-04-11 (Crawled : 00:00) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| -8.18% | O: -0.36% H: 0.0% C: 0.0%
kidney publication study

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| -8.41% | O: 0.92% H: 0.26% C: -2.26%
test for heart

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| -4.37% | O: 2.12% H: 4.35% C: 2.25%
bladder positive cancer trial

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| -3.12% | O: -0.6% H: 2.8% C: 2.25%
cancer trials trial

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Published: 2024-03-18 (Crawled : 12:30) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| -1.02% | O: 0.19% H: 1.46% C: 0.48%
cancer trial

Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| -0.75% | O: 0.07% H: 1.68% C: 1.65%
breast meeting

Natera to Participate in March Investor Conferences
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| 15.75% | O: 11.99% H: 5.68% C: 0.89%

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
NTRA | News S | $88.61 3.91% 3.8% 5

Health Services

| 26.57% | O: -1.86% H: 2.81% C: 2.47%
conference

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-011082	4	2024-04-18	2024-04-16	Sell	S	53489	117560
0001415889-24-011082	4	2024-04-18	2024-04-16	Sell	S	26511	171049
0001415889-24-011081	4	2024-04-18	2024-04-15	Sell	S	100	227710
0001415889-24-011081	4	2024-04-18	2024-04-15	Sell	S	2411	227810
0001415889-24-011081	4	2024-04-18	2024-04-15	Sell	S	4305	230221
0001415889-24-010341	4	2024-04-05	2024-04-03	Sell	S	7863	321031
0001415889-24-010341	4	2024-04-05	2024-04-03	Sell	S	10138	328894
0001415889-24-010341	4	2024-04-05	2024-04-03	Sell	S	8699	339032
0001415889-24-010340	4	2024-04-05	2024-04-02	Sell	S	1378	70646